UroGen Pharma URGN
NASDAQ URGN
$41.40 +0.85 (+2.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

UroGen Pharma (URGN) Cash from Investing Activities (2017 - 2026)

Updated

UroGen Pharma (URGN) posted Cash from Investing Activities of $1.67 million for Q2 2026, down 94.1% from $28.41 million a year earlier.

Analysis

UroGen Pharma (URGN) Cash from Investing Activities (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Investing Activities at UroGen Pharma was $40.1 million; for FY2025, it came in at $61.56 million.

  • Annual Cash from Investing Activities shows a five-year compound annual growth rate of -8.0% (FY2020 to FY2025).
  • In prior years, UroGen Pharma's Cash from Investing Activities was -$20.61 million in FY2024, -$953,000 in FY2023, $1.06 million in FY2022 (-73.9%) and $4.07 million in FY2021 (-95.6%).
  • Quarterly Cash from Investing Activities has run from a low of -$106.75 million in Q3 2024 to a high of $60.62 million in Q4 2024 over five years.
  • The strongest year-over-year quarter for Cash from Investing Activities in the past five years was Q2 2024, with growth of 222.5%; the weakest was Q2 2026, with a decline of 94.1%.
  • According to Business Quant data, Cash from Investing Activities for the three prior quarters was -$20.69 million (Q1 2026), $27.72 million (Q4 2025) and $31.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 UroGen Pharma 2.02 Bn 1.53 Bn 65.88 Mn 1.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.67 Mn
Mar 31, 2026 -20.69 Mn
Dec 31, 2025 27.72 Mn
Sep 30, 2025 31.40 Mn
Jun 30, 2025 28.41 Mn
Mar 31, 2025 -25.96 Mn
Dec 31, 2024 60.62 Mn
Sep 30, 2024 -106.75 Mn
Jun 30, 2024 12.00 Mn
Mar 31, 2024 13.52 Mn
Dec 31, 2023 -11.34 Mn
Sep 30, 2023 401,000.00
Jun 30, 2023 3.72 Mn
Mar 31, 2023 6.27 Mn
Dec 31, 2022 23.11 Mn
Sep 30, 2022 -35.49 Mn
Jun 30, 2022 -151,000.00
Mar 31, 2022 13.60 Mn
Dec 31, 2021 9.13 Mn
Sep 30, 2021 10.66 Mn
API Access

UroGen Pharma Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=URGN&period=max&api_key=YOUR_API_KEY